Cargando…

Cell Therapy: A Safe and Efficacious Therapeutic Treatment for Alzheimer’s Disease in APP+PS1 Mice

Previously, our lab was the first to report the use of antigen-sensitized dendritic cells as a vaccine against Alzheimer’s disease (AD). In preparation of this vaccine, we sensitized the isolated dendritic cells ex vivo with Aβ peptide, and administered these sensitized dendritic cells as a therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nabar, Neel R., Yuan, Fang, Lin, Xiaoyang, Wang, Li, Bai, Ge, Mayl, Jonathan, Li, Yaqiong, Zhou, Shu-Feng, Wang, Jinhuan, Cai, Jianfeng, Cao, Chuanhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513317/ https://www.ncbi.nlm.nih.gov/pubmed/23226497 http://dx.doi.org/10.1371/journal.pone.0049468

Ejemplares similares

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice
por: Wang, Yanhong, et al.
Publicado: (2022)

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
por: Shen, Ning, et al.
Publicado: (2019)

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
por: Fihurka, Oksana, et al.
Publicado: (2022)

MiR-409-5p as a Regulator of Neurite Growth Is Down Regulated in APP/PS1 Murine Model of Alzheimer’s Disease
por: Guo, Jing, et al.
Publicado: (2019)

PT573. The effects of intestinal endotoxemia on APP, PS1 and BACE expression in Alzheimer’s disease
por: Han, Bai, et al.
Publicado: (2016)

The Immune System as a Therapeutic Target for Alzheimer’s Disease
por: Zieneldien, Tarek, et al.
Publicado: (2022)

Isolation Housing Exacerbates Alzheimer’s Disease-Like Pathophysiology in Aged APP/PS1 Mice
por: Huang, Huang, et al.
Publicado: (2015)

Human Neural Stem Cell Transplantation Rescues Cognitive Defects in APP/PS1 Model of Alzheimer’s Disease by Enhancing Neuronal Connectivity and Metabolic Activity
por: Li, Xueyuan, et al.
Publicado: (2016)

Novel Botanical Therapeutic NB-02 Effectively Treats Alzheimer’s Neuropathophysiology in an APP/PS1 Mouse Model
por: Lee, Yee Fun, et al.
Publicado: (2021)

Identifiable biomarker and treatment development using HIV-1 long term non-progressor sera
por: Hao, Yuxia, et al.
Publicado: (2015)

Effects of multi-mode physical stimulation on APP/PS1 Alzheimer's disease model mice
por: Liu, Shupeng, et al.
Publicado: (2022)

Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice
por: Wang, Zigao, et al.
Publicado: (2017)

Impact of Donepezil Supplementation on Alzheimer’s Disease-like Pathology and Gut Microbiome in APP/PS1 Mice
por: Li, Yuan, et al.
Publicado: (2023)

Milrinone Ameliorates the Neuroinflammation and Memory Function of Alzheimer’s Disease in an APP/PS1 Mouse Model
por: Chen, Qingyou, et al.
Publicado: (2021)

Neuroprotective Effects of Leptin on the APP/PS1 Alzheimer’s Disease Mouse Model: Role of Microglial and Neuroinflammation
por: Ma, Jing, et al.
Publicado: (2023)

Integrated untargeted and targeted metabolomics to reveal therapeutic effect and mechanism of Alpiniae oxyphyllae fructus on Alzheimer’s disease in APP/PS1 mice
por: Zhou, Shengnan, et al.
Publicado: (2023)

S-adenosylmethionine and S-adenosylhomocysteine levels in the aging brain of APP/PS1 Alzheimer mice
por: Hooijmans, Carlijn R., et al.
Publicado: (2009)

Transcranial Electromagnetic Treatment “Rebalances” Blood and Brain Cytokine Levels in Alzheimer’s Patients: A New Mechanism for Reversal of Their Cognitive Impairment
por: Cao, Chuanhai, et al.
Publicado: (2022)

Sevoflurane Promotes Neurodegeneration Through Inflammasome Formation in APP/PS1 Mice
por: Li, Guohua, et al.
Publicado: (2021)

Differential methylation of circRNA m6A in an APP/PS1 Alzheimer's disease mouse model
por: Zhang, Xiao, et al.
Publicado: (2023)

Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012)

NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice
por: Heneka, Michael T., et al.
Publicado: (2012)

Gut microbiota may be involved in Alzheimer’s disease pathology by dysregulating pyrimidine metabolism in APP/PS1 mice
por: Feng, Min, et al.
Publicado: (2022)

The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease
por: Tian, Yanna, et al.
Publicado: (2023)

Fecal microbiota transplantation alleviated Alzheimer’s disease-like pathogenesis in APP/PS1 transgenic mice
por: Sun, Jing, et al.
Publicado: (2019)

The Transcription Factor EB Links Cellular Stress to the Immune Response  
por: Nabar, Neel R., et al.
Publicado: (2017)

Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice
por: Hiltunen, Mikko, et al.
Publicado: (2012)

Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease
por: Webster, Scott J, et al.
Publicado: (2013)

Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
por: Zhang, Xueju, et al.
Publicado: (2020)

Neuroprotective effects of resistance physical exercise on the APP/PS1 mouse model of Alzheimer’s disease
por: Campos, Henrique Correia, et al.
Publicado: (2023)

Ethanol exposure alters Alzheimer’s-related pathology, behavior, and metabolism in APP/PS1 mice
por: Day, Stephen M., et al.
Publicado: (2023)

Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer’s disease-like pathologies in APP/PS1 mouse model
por: Yang, Cui-cui, et al.
Publicado: (2020)

Klotho overexpression improves amyloid‐β clearance and cognition in the APP/PS1 mouse model of Alzheimer's disease
por: Zhao, Yue, et al.
Publicado: (2020)

DNA vaccines targeting amyloid-β oligomer ameliorate cognitive deficits of aged APP/PS1/tau triple-transgenic mouse models of Alzheimer’s disease
por: Sha, Sha, et al.
Publicado: (2022)

Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse
por: Wang, Shang, et al.
Publicado: (2023)

New insight into Alzheimer's disease: Light reverses Aβ-obstructed interstitial fluid flow and ameliorates memory decline in APP/PS1 mice
por: Yue, Xiangpei, et al.
Publicado: (2019)

Tieguanyin Oolong Tea Extracts Alleviate Behavioral Abnormalities by Modulating Neuroinflammation in APP/PS1 Mouse Model of Alzheimer’s Disease
por: Kang, Hyunuk, et al.
Publicado: (2021)

Expression of ErbB4 in the neurons of Alzheimer's disease brain and APP/PS1 mice, a model of Alzheimer's disease
por: Woo, Ran-Sook, et al.
Publicado: (2011)

Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD
por: Mayl, Keith, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1h2ad9asfs19e0lfrnsm7bmon